Your browser doesn't support javascript.
loading
Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy.
Ofotokun, Ighovwerha; Chuck, Susan K; Binongo, Jose N; Palau, Mauricio; Lennox, Jeffrey L; Acosta, Edward P.
Affiliation
  • Ofotokun I; Department of Medicine, Division of Infectious Diseases, Emory University of Medicine, 69 Jesse Hill Jr Drive Atlanta, GA 30303, USA.
J Clin Pharmacol ; 47(8): 970-7, 2007 Aug.
Article in En | MEDLINE | ID: mdl-17615254
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Adenine / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors / Ritonavir / Organophosphonates Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Pharmacol Year: 2007 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Adenine / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors / Ritonavir / Organophosphonates Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Pharmacol Year: 2007 Document type: Article Affiliation country: Country of publication: